- within Food, Drugs, Healthcare and Life Sciences topic(s)
- within Consumer Protection, International Law and Antitrust/Competition Law topic(s)
- with readers working within the Aerospace & Defence and Media & Information industries
The journey of a life sciences invention from laboratory discovery to global commercialization is fraught with both opportunitiesand risks. From pharmaceuticals and biotechnology to medical devices, the life sciences sector is one of the most heavily regulated and globally integrated industries.
As innovations cross borders, so do the legal complexitiessurroundingintellectual property (IP) rights, regulatory approvals, licensing formalities, and technology transfer restrictions. For businesses, universities, and multinational corporations, understanding and managing these challenges is crucial to ensuring effective commercialization and risk mitigation. This article explores the critical legal and regulatory issues that shape the licensing of life sciences IP, with a focus on Nigeria as a case study.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
